As the U.S. stock market experiences a pause following a nine-session winning streak, investors are closely watching developments around tariffs and Federal Reserve decisions, which have introduced uncertainty into economic forecasts. In this environment, identifying stocks that might be priced below their fair value can offer potential opportunities for investors seeking to navigate the current market conditions. Top 10 Undervalued Stocks Based On Cash Flows In The United States Name Current Price Fair Value (Est) Discount (Est) FB Financial (NYSE:FBK) $44.62 $89.12 49.9% MINISO Group Holding (NYSE:MNSO) $18.53 $36.62 49.4% MetroCity Bankshares (NasdaqGS:MCBS) $28.33 $55.11 48.6% Owens Corning (NYSE:OC) $144.46 $284.31 49.2% German American Bancorp (NasdaqGS:GABC) $38.57 $74.67 48.3% Pure Storage (NYSE:PSTG) $47.58 $93.52 49.1% Ready Capital (NYSE:RC) $4.44 $8.67 48.8% HealthEquity (NasdaqGS:HQY) $91.42 $179.14 49% Live Oak Bancshares (NYSE:LOB) $26.93 $52.48 48.7% Coeur Mining (NYSE:CDE) $5.45 $10.87 49.8% Click here to see the full list of 176 stocks from our Undervalued US Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. Freshpet Overview: Freshpet, Inc. manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe with a market cap of approximately $3.72 billion. Operations: Freshpet generates revenue through the production and sale of natural fresh meals and treats for dogs and cats across the United States, Canada, and Europe. Estimated Discount To Fair Value: 13.9% Freshpet's recent earnings report showed a net loss of US$12.7 million for Q1 2025, contrasting with a net income of US$18.6 million the previous year, yet it remains undervalued based on discounted cash flow analysis. Trading at US$79.09, below its fair value estimate of US$91.81, Freshpet is expected to see significant annual profit growth of 36.5% over the next three years despite slower revenue growth projections compared to market expectations. Insights from our recent growth report point to a promising forecast for Freshpet's business outlook. Click to explore a detailed breakdown of our findings in Freshpet's balance sheet health report.NasdaqGM:FRPT Discounted Cash Flow as at May 2025 REV Group Overview: REV Group, Inc. designs, manufactures, and distributes specialty vehicles and related aftermarket parts and services in North America and internationally, with a market cap of approximately $1.81 billion. Operations: The company's revenue segments include Specialty Vehicles, generating $1.68 billion, and Recreational Vehicles, contributing $640.20 million. Story Continues Estimated Discount To Fair Value: 27.3% REV Group is trading at US$35.64, significantly below its estimated fair value of US$48.99, indicating undervaluation based on discounted cash flow analysis. Despite a decrease in first-quarter sales to US$525.1 million and net income dropping to US$18.2 million, earnings are projected to grow substantially by 23.76% annually over the next three years, outpacing the broader U.S. market's growth expectations while maintaining strong operational execution and shareholder returns through dividends and buybacks. Upon reviewing our latest growth report, REV Group's projected financial performance appears quite optimistic. Get an in-depth perspective on REV Group's balance sheet by reading our health report here.NYSE:REVG Discounted Cash Flow as at May 2025 Warby Parker Overview: Warby Parker Inc. operates in the United States and Canada, offering eyewear products, with a market capitalization of approximately $2.05 billion. Operations: The company's revenue is primarily derived from its Medical - Optical Supplies segment, totaling $771.32 million. Estimated Discount To Fair Value: 28.9% Warby Parker, trading at US$16.96, is significantly undervalued with a fair value estimate of US$23.87 according to discounted cash flow analysis. Despite a net loss reduction to US$20.39 million for 2024, the company anticipates robust revenue growth between 14% and 16% in 2025, bolstered by strategic partnerships like the Target collaboration. Earnings are projected to grow substantially by 76.4% annually over three years as profitability improves beyond market averages. The growth report we've compiled suggests that Warby Parker's future prospects could be on the up. Click here and access our complete balance sheet health report to understand the dynamics of Warby Parker.NYSE:WRBY Discounted Cash Flow as at May 2025 Seize The Opportunity Unlock our comprehensive list of 176 Undervalued US Stocks Based On Cash Flows by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Curious About Other Options? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGM:FRPTNYSE:REVG and NYSE:WRBY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Freshpet And 2 Other Stocks That Might Be Priced Below Fair Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...